Frontiers in Bioscience-Landmark (FBL) is an international peer-reviewed open access journal dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells. The journal serves as a critical platform for disseminating cutting-edge human biological research, encompassing studies related to biochemistry, biophysics, physiology, pathology, biotechnology, and bioinformatics .
For researchers studying human biological systems, FBL provides high visibility through indexing in major scientific databases including SCIE (Web of Science), MEDLINE (PubMed), Scopus, and DOAJ . This visibility ensures that published human studies reach a wide academic audience, making FBL a strategic venue for maximizing research impact. The journal's membership in the Committee on Publication Ethics (COPE) also ensures that published human studies adhere to rigorous ethical standards, which is particularly important for research involving human subjects or samples.
FBL publishes a diverse range of human cellular and molecular studies, with recent publications highlighting the breadth of research areas applicable to human biology. Based on current indexing, these include:
Epigenetic and genome stability studies - such as research on linker histones and their role in maintaining genome stability and cellular aging processes
Immunological research - including studies examining psychic stress effects on contact sensitivity, cell proliferation, and cytokine production
Signaling pathway investigations - exemplified by research on the Nrf2 Signaling Pathway in relation to Mycoplasma infections
Neurodegenerative disease research - particularly studies identifying novel plasma biomarkers for conditions like Alzheimer's Disease using advanced techniques such as organotypic brain slice and microcontact printing
The journal's focus emphasizes molecular mechanisms underlying human health and disease, with particular attention to translational aspects that bridge fundamental research with clinical applications. This makes FBL particularly valuable for researchers investigating human cellular and molecular processes with potential medical implications.
Designing robust experiments for human cell studies requires careful consideration of methodology and experimental design principles. Two primary approaches should be considered:
Laboratory-Controlled Experiments:
These experiments offer precise control of variables and are ideal for mechanistic studies of human cells. Key methodological considerations include:
Implementing strict randomization protocols for sample allocation
Establishing appropriate controls (positive, negative, vehicle)
Standardizing protocols to enable replication by other researchers
Determining appropriate sample sizes through power analysis
Strengths: Laboratory experiments provide precise control of external and internal factors, enable random assignment of samples, and allow identification of cause-effect relationships with high accuracy .
Limitations: These approaches may lack ecological validity as lab environments don't reflect natural conditions, and observer effects might bias results (Hawthorne Effect) .
Field Experiments:
Field experiments are conducted in natural settings with manipulation of the "cause" aspect but limited control over other variables . These are particularly valuable for validating laboratory findings in more realistic contexts.
Applications: Often used for validating laboratory protocols or collecting broader feedback on methodological approaches that were initially tested under controlled conditions .
Selection between these approaches should be guided by research questions, available resources, and the balance needed between control and ecological validity. For most human cell studies, a hybrid approach starting with controlled experiments followed by validation in more naturalistic settings often yields the most comprehensive results.
Analysis of protein localization in human cells, such as fibrillarin, requires specialized techniques that combine molecular biology with advanced microscopy. Based on established methodologies, researchers should consider the following approach:
Fusion Protein Constructs:
Generate constructs of full-length protein and truncated mutants fused to fluorescent reporters like GFP
Use standard cloning techniques with appropriate restriction sites (e.g., XbaI) to fuse the protein in frame to the GFP coding sequence
Create deletion mutants to identify specific targeting domains within the protein
Cell Culture and Transfection:
Imaging Methodology:
Validation Approaches:
For dynamic studies of protein mobility, time-lapse confocal microscopy remains the gold standard, allowing researchers to track processes such as the fusion and splitting of nuclear bodies over time, though these events typically occur at low frequencies .
Deep learning approaches offer powerful tools for analyzing complex human biological data. Implementing these approaches for human studies requires a systematic methodology:
Data Preparation and Preprocessing:
Model Architecture Selection:
When analyzing human full-body images or similar biometric data, three primary architectures have demonstrated effectiveness:
| Architecture | Characteristics | Performance for Human Data |
|---|---|---|
| Convolutional Neural Network (CNN) | Basic architecture with convolutional layers | Serves as baseline model |
| ResNet-50 | 50-layer network with residual connections | Highest accuracy: 79.18% for age, 95.43% for gender, 85.60% for height, 81.91% for weight |
| VGG-16 | 16-layer network with uniform architecture | Effective when transfer learning from pre-trained models |
The ResNet-50 architecture has demonstrated superior performance in various human biometric estimation tasks .
Training Implementation:
Select appropriate loss functions based on the parameter being estimated
Implement transfer learning by initializing with weights pre-trained on large datasets
Apply regularization techniques to prevent overfitting, especially with limited data
Validation Strategy:
Implement cross-validation to ensure robustness
Compare performance across different architectures
Analyze model performance across demographic subgroups to identify potential biases
This methodological framework provides a structured approach for applying deep learning to human biological data analysis, allowing researchers to select and optimize techniques appropriate for their specific research questions.
Addressing contradictions in human research data requires sophisticated approaches combining traditional analysis with newer computational techniques:
Contradiction Detection Frameworks:
Modern approaches leverage large language models (LLMs) and linguistic rules to identify contradicting patterns in research data . This involves:
Structured Analysis of Contradiction Types:
| Contradiction Type | Characteristics | Detection Methodology |
|---|---|---|
| Logical Contradiction | Direct opposition in claims | Natural language processing and logical inference |
| Statistical Contradiction | Significant differences in values | Meta-analysis and heterogeneity assessment |
| Methodological Contradiction | Different methods yielding opposite results | Research design comparison frameworks |
| Temporal Contradiction | Findings that diverge over time | Longitudinal analysis of publication patterns |
Resolution Approaches:
Meta-analytical techniques: Systematically combine data from multiple studies to identify sources of contradiction and estimate true effect sizes
Bayesian methods: Incorporate prior knowledge and update confidence based on new evidence
Multilab replication: Implement standardized protocols across multiple labs to verify findings
Preregistration: Reduce publication bias by documenting methods and analyses before conducting studies
Computational Implementation:
Recent work demonstrates the potential of generating prototype contradiction datasets using large language models with specific instructions to create contradicting statements . These approaches show promise in terms of coherence and variety but require further refinement through manual validation before deployment in machine learning systems .
By systematically applying these techniques, researchers can better identify, categorize, and resolve contradictions in human research data, ultimately improving the reliability and reproducibility of scientific findings.
For studying dynamic protein behavior in human cells, such as fibrillarin mobility between nucleoli and Cajal bodies (CBs), a comprehensive methodological approach combining molecular techniques with advanced imaging is recommended:
Molecular Construct Design:
Live Cell Imaging Setup:
Culture cells on glass-bottom dishes in media optimized for fluorescence imaging (HEPES-buffered, phenol red-free)
Maintain physiological conditions using temperature-controlled stages (37°C) and appropriate CO2 levels
Employ high-sensitivity cameras (e.g., cooled CCDs) for detection of low signal intensities
Dynamic Analysis Techniques:
| Technique | Application | Information Obtained |
|---|---|---|
| Time-lapse confocal microscopy | Tracking protein movement over time | Movement patterns, fusion/splitting events |
| FRAP (Fluorescence Recovery After Photobleaching) | Measuring protein mobility | Diffusion rates, bound vs. mobile fractions |
| Single particle tracking | Following individual molecules | Detailed movement patterns, interaction kinetics |
Specific Analyses for Nuclear Bodies:
Validation Controls:
Implementation example: Studies of fibrillarin in human cells have successfully used this approach to demonstrate that specific structural domains (particularly the second spacer domain and carboxy terminal alpha-helix domain) target fibrillarin to nucleolar transcription centers and Cajal bodies, respectively .
Developing large-scale human biometric datasets requires careful consideration of collection, processing, and validation methodologies. Based on successful implementations like the Celeb-FBI dataset, the following approach is recommended:
Dataset Design and Collection:
Data Processing Pipeline:
Quality Control Measures:
Manual verification of subset of data points
Cross-validation of attributes from multiple sources when possible
Outlier detection and handling
Assessment of attribute accuracy and precision
Benchmark Testing Framework:
The Celeb-FBI approach demonstrates an effective methodology, creating a dataset of 7,211 full-body images with detailed attribute information, then evaluating performance using multiple deep learning approaches:
| Model Architecture | Age Accuracy | Gender Accuracy | Height Accuracy | Weight Accuracy |
|---|---|---|---|---|
| Basic CNN | Lower | Moderate | Moderate | Moderate |
| ResNet-50 | 79.18% | 95.43% | 85.60% | 81.91% |
| VGG-16 | Moderate | High | Moderate | Moderate |
ResNet-50 consistently delivered superior performance across all biometric parameters .
Documentation and Distribution:
Comprehensive documentation of collection methodology
Clear description of preprocessing steps
Ethical statements regarding data usage
Accessibility considerations for research community
By following this methodological framework, researchers can develop robust human biometric datasets that enable advanced analysis while maintaining ethical standards and minimizing potential biases.
Optimizing time-lapse microscopy for long-term human cell studies requires careful attention to both technical parameters and biological considerations:
Sample Preparation for Extended Imaging:
Select appropriate culture vessels (glass-bottom dishes or chambers)
Formulate media specifically for long-term imaging:
Determine optimal cell density that allows for growth while preventing overcrowding
Environmental Control Systems:
Acquisition Parameter Optimization:
| Parameter | Optimization Strategy | Biological Consideration |
|---|---|---|
| Temporal resolution | Balance information needs with phototoxicity | Match to expected rate of cellular processes |
| Exposure settings | Use lowest power yielding acceptable signal | Minimize photobleaching and phototoxicity |
| Z-sampling | For 3D structures, optimize step size | Balance completeness with acquisition speed |
| Field of view selection | Choose representative regions | Consider cell migration patterns |
| Autofocus mechanism | Implement reliable focus maintenance | Prevent data loss due to drift |
Hardware Selection:
Experimental Controls and Validation:
Include non-imaged control samples to assess phototoxicity effects
Verify that fluorescent protein expression doesn't alter normal cellular functions
Compare with fixed-cell imaging to confirm that live-cell dynamics reflect natural processes
Consider using multiple fluorophores to track different cellular components simultaneously
Analysis Workflows:
By systematically implementing these optimizations, researchers can achieve high-quality time-lapse imaging of human cells over extended periods while minimizing artifacts and maintaining cell viability throughout the experiment.
Transfection of difficult-to-transfect human cell lines has seen significant methodological advancements in recent years. Researchers should consider these optimized approaches:
Lipid-Based Transfection Enhancements:
Next-generation lipid formulations with reduced toxicity
Optimization of DNA:lipid ratios for cell type-specific protocols
Serum-resistant formulations that maintain efficiency in complete media
Example implementation: DOTAP transfection at 60% cell confluence followed by analysis 4-48 hours post-transfection
Physical Methods for Recalcitrant Cell Lines:
| Method | Principle | Best Application Scenario |
|---|---|---|
| Nucleofection | Combination of electroporation with cell-specific solutions | Primary cells, stem cells, neurons |
| Microinjection | Direct injection into individual cells | Single-cell studies, precise dosage control |
| Acoustic transfection | Ultrasound-mediated membrane permeabilization | Gentle approach for sensitive cell types |
| Biolistic delivery | DNA-coated gold particles accelerated into cells | Tissue explants, organoids |
Viral Vector Approaches:
Lentiviral systems for stable integration in non-dividing cells
Adeno-associated virus (AAV) for long-term expression with low immunogenicity
Sendai virus for RNA delivery without genomic integration
Hybrid vectors combining advantages of multiple viral systems
Optimization Protocol for Challenging Cell Lines:
Selection and Validation of Stable Transfectants:
Grow transfected cells in selection media (e.g., 400 μg/ml G418) to isolate stable transfectants
Analyze approximately 30 stable clones to identify optimal expression patterns
Verify that expression doesn't alter cellular structures or functions
Implement fluorescence-activated cell sorting (FACS) for enrichment of expressing cells
Emerging Technologies:
CRISPR-based knock-in strategies for endogenous tagging
Nanoparticle-mediated delivery systems with cell-targeting capabilities
Cell-penetrating peptides conjugated to nucleic acids
mRNA transfection for transient expression without nuclear entry requirements
By systematically implementing these advanced methodologies, researchers can achieve successful transfection in traditionally difficult human cell lines, enabling sophisticated studies of protein localization and dynamics.
Fibrillarin is characterized by an N-terminal repetitive domain rich in glycine and arginine residues, a central RNA-binding domain, and a C-terminal domain that exhibits methyltransferase activity . The enzyme is primarily located in the dense fibrillar component (DFC) of the nucleolus, where it associates with small nucleolar RNAs (snoRNAs) such as U3, U8, and U13 .
The primary function of fibrillarin is to catalyze the 2’-O-methylation of rRNA, a critical step in the maturation and assembly of ribosomes . This methylation process is essential for the proper folding and stability of rRNA, which in turn ensures the accurate translation of genetic information into proteins .
Fibrillarin has been implicated in various diseases, particularly cancer. Studies have shown that the overexpression of fibrillarin is associated with poor prognosis in breast cancer . Interestingly, both hyperactivation and hypoactivation of ribosome biogenesis, mediated by fibrillarin, have been linked to distinct molecular traits in tumors . This dual association suggests that fibrillarin could serve as a valuable biomarker for cancer diagnosis and prognosis .
Additionally, fibrillarin is recognized by antisera from approximately 8% of patients with the autoimmune disease scleroderma, indicating its potential role in autoimmune disorders .
Recombinant fibrillarin is produced using recombinant DNA technology, which involves cloning the FBL gene into an expression vector and introducing it into a host organism, such as bacteria or yeast. The host organism then expresses the fibrillarin protein, which can be purified and used for various research and therapeutic applications.
Recombinant fibrillarin is valuable for studying the enzyme’s structure, function, and interactions with other molecules. It also provides a tool for investigating the molecular mechanisms underlying ribosome biogenesis and its dysregulation in diseases.